Mangoceuticals, Inc.'s total assets for Q4 2024 were $15.37M, an increase of 3.91% from the previous quarter. MGRX total liabilities were $1.43M for the fiscal quarter, a 1.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.